T1	Participants 488 496	Patients
T2	Participants 648 656	Patients
T3	Participants 367 431	1298 patients were enrolled in a double-blind multicentric study
T4	Participants 1132 1139	patient
T5	Participants 1288 1298	all groups
T6	Participants 1474 1494	subgroup of symptoms
